Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 211 companies set new 52-week lows.
HC Wainwright & Co. Initiates Coverage On Benitec Biopharma with Buy Rating, Announces Price Target of $10
HC Wainwright & Co. analyst Patrick Trucchio initiates coverage on Benitec Biopharma (NASDAQ:BNTC) with a Buy rating and announces Price Target of $10.
Benitec Biopharma Q2 EPS $(0.59) Up From $(0.76) YoY, Sales $25.00K Up From $1.00K YoY
Benitec Biopharma (NASDAQ:BNTC) reported quarterly losses of $(0.59) per share. This is a 22.37 percent increase over losses of $(0.76) per share from the same period last year. The company reported $25.00 thousand in
Benitec Pharma Shares At Session High Following Circulation Of US Patent & Trademark Office Abstract For Co.’s ‘Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof’
https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=11142765&OS=11142765&RS=11142765
Benitec Biopharma Provides Regulatory Updates for the BB-301 Development Program; BB-301 Phase 1b/2a Clinical Trial to Begin in 2022
Benitec Biopharma Inc. (NASDAQ: BNTC), a development-stage biotechnology company focused on the advancement of novel genetic medicines, today announced significant progress regarding the regulatory interactions
Benitec Biopharma Files For U.S. Patent Application Titled ‘REAGENTS FOR TREATMENT OF HEPATITIS B VIRUS INFECTION’
https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PG01&s1=20210177885&OS=20210177885&RS=20210
77 Biggest Movers From Yesterday
Gainers
AMC Entertainment Holdings, Inc. (NYSE: AMC) shares surged 23.7% to close at $12.77.
Moxian, Inc. (NASDAQ: MOXC) jumped 23.6% to close at $9.52.